How Retired Pro Athletes Use Psychedelics

December 18, 2020 16:02:34

Former UFC fighters Dean Lister and Ian McCall, former NHL player Daniel Carcillo and former NFL player Kerry Rhodes are a few well-known athletes who current using plant medicines such as psilocybin mushrooms and ayahuasca to help manage brain trauma symptoms and heal their PTSD.

Carcillo suffered from mental and physical trauma following the effects of repeated concussions after retiring from the NHL. It wouldn’t have been easy to spot though, given that from the outside, he seemed to have it all — from a successful career to a comfortable home and a lovely family.

CTE, or chronic traumatic encephalopathy, presents in many ways, with one of the symptoms being depression. The brain condition has been linked to repeated blows to an individual’s head. Other symptoms include erratic behavior, confusion, personality changes and memory loss. While a definitive diagnosis can only be made when an autopsy is conducted, results from a study conducted in 2017 show that chronic trauma encephalopathy was discovered in 91% of college football athletes and 99% of former NFL players who were studied.

Throughout his professional hockey career that spanned more than a decade, Carcillo was diagnosed with seven concussions. He decided to try ayahuasca after various SSRIs and psychotherapy hadn’t helped. Ayahuasca contains DMT, a psychedelic compound that is regarded as a powerful medicine by the indigenous cultures of South America who brew it. Following his ayahuasca ceremony months later, Carcillo explained that his insomnia, memory issues, headaches, slurred speech and head-pressure symptoms had completely disappeared, adding that he was experiencing little to no anxiety or depression.

Rhodes recounts his experience, which is similar to that of Carcillo, noting that his experience with psychedelics brought back his memory, completely eliminated his pain and headaches, and helped him deal with his CTE fear, which caused great improvements in the quality of his life.

McCall, on the other hand, who had fought in professional MMA leagues and the UFC for a decade and a half, had suffered injuries multiple times, which left him with a serious opiate addiction. He explained that his experimentation with psychedelics helped cure him of his suicidal thoughts as well as his addiction.

The experiences of these athletes coupled with already existing clinical research on psychedelics show that psychedelic drugs can, in fact. help treat many conditions, ranging from PTSD to anxiety, depression to addiction, which in the end could provide relief to many individuals suffering from these conditions.

The growing awareness about the potential benefits of functional mushrooms as well as psychedelic substances has given rise to a number of companies intent on developing products using these substances. One such company is Rritual Superfoods Inc., a firm that makes an array of premium products aimed at boosting immunity, lowering stress levels and boosting cognitive function. Adaptogens, functional mushrooms and other carefully selected superfoods are used in the making of these high-end products.

NOTE TO INVESTORS: The latest news and updates relating to Rritual Superfoods Inc. are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.